Intervention Protocol

Octreotide for inoperable malignant bowel obstruction

  1. Li Ma2,
  2. Ting Wang3,
  3. Bin Ma1,*,
  4. Yali Liu1

Editorial Group: Cochrane Colorectal Cancer Group

Published Online: 17 MAR 2010

Assessed as up-to-date: 5 FEB 2010

DOI: 10.1002/14651858.CD008396


How to Cite

Ma L, Wang T, Ma B, Liu Y. Octreotide for inoperable malignant bowel obstruction (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 3. Art. No.: CD008396. DOI: 10.1002/14651858.CD008396.

Author Information

  1. 1

    Lanzhou University, Centre of Evidence Based Medicine, Lanzhou City, Gansu, China

  2. 2

    Tianjin Medical University General Hospital, Oncology Department, Tianjin, China

  3. 3

    Sichuan University, West China Hospital, Chengdu, SIchuan, China

*Bin Ma, Centre of Evidence Based Medicine, Lanzhou University, 199 Dongang West Road, Lanzhou City, Gansu, 730000, China. Kitty-ml@126.com. Kitty-1999@163.com.

Publication History

  1. Publication Status: New
  2. Published Online: 17 MAR 2010

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.